Skip to content

Construction and evaluation of a machine-learning-based prediction model for pneumonia in patients with acute leukemia.

Sep 2026 · Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis · Vol 170, pp. 108302 · 0 citations · 31 references
Medicine

TL;DR

An interpretable XGBoost model that accurately predicts pneumonia risk in AL patients based on routine admission data is developed and validated and provides actionable risk stratification to inform preemptive diagnostic and therapeutic strategies.

Abstract

Background

Pulmonary infection is a major cause of mortality in individuals diagnosed with acute leukemia (AL). However, conventional risk assessment tools often fail to adequately capture the complex, nonlinear interactions among clinical factors that contribute to pneumonia susceptibility. While machine learning (ML) offers potential advantages for such tasks, comparative evaluations of multiple ML algorithms for early pneumonia prediction in AL populations remain limited. This study sought to develop and rigorously validate an ML-based predictive model using readily accessible admission variables to enable early identification of high-risk patients and support proactive clinical management.

Method

We conducted a retrospective analysis of 2018 AL patients hospitalized at Zhangzhou Affiliated Hospital of Fujian Medical University between January 2019 and August 2025. Demographic information, comorbidities, vital signs, and laboratory parameters were retrieved from electronic medical records. Least absolute shrinkage and selection operator (LASSO) regression with cross-validation was applied to the training cohort for feature selection. Subsequently, seven ML algorithms were employed to construct predictive models. Model performance was assessed based on discrimination (area under the receiver operating characteristic curve [AUC]), calibration (Brier score and calibration plots), and clinical utility (decision curve analysis [DCA]). The optimal model was further interpreted using Shapley Additive Explanations (SHAP).

Results

The cohort was randomly split into training (n = 1413) and validation (n = 605) sets at a 7:3 ratio. LASSO regression identified 14 key predictors from the initial variables. Among the seven evaluated models, the extreme gradient boosting (XGBoost) algorithm demonstrated superior predictive performance, achieving the highest AUC (0.767) and accuracy (0.734) in the validation cohort. Calibration plots and DCA consistently indicated the superiority of XGBoost over comparator models. SHAP analysis revealed the top ten contributors to pneumonia risk: decreased levels of calcium, sodium, and platelets, alongside elevated age, body temperature, hemoglobin, red blood cells, heart rate, mean corpuscular hemoglobin concentration (MCHC), and white blood cells.

Conclusion

We developed and validated an interpretable XGBoost model that accurately predicts pneumonia risk in AL patients based on routine admission data. This tool provides actionable risk stratification to inform preemptive diagnostic and therapeutic strategies.

View source

Similar papers

Open access Sep 2026

Machine learning-based early prediction of severe pneumonia risk in hospitalized leukemia patients: a dual-center retrospective cohort study

Severe pneumonia is a major infectious complication in patients with leukemia and may rapidly progress to respiratory failure or septic shock. Disease- and treatment-related immunosuppression increases susceptibility, yet population-specific early risk-stratification tools are limited. To develop and externa...

Jian Huang, Qin-Liang Wu, Yi-Xin Zhang et al. · 0 citations
Open access Sep 2026

Development and validation of an interpretable machine learning model for pulmonary heart disease in patients with pneumoconiosis

A machine learning model based on routinely available data is developed and validated to support early risk stratification and clinical decision-making in resource-limited environments and indicates that machine learning models, particularly LR, may be useful for PHD risk screening and stratification among patients wit...

Yi-Fei Xie, Yi Feng, Xing-Lin Wan et al. · 0 citations
Open access Sep 2026

Determinants and Prediction of In-Hospital Mortality in Pneumonia Patients Using Machine Learning Models

Machine-learning models, particularly RF, SVM, and NNET, outperformed LR in internal prediction, however, due to the retrospective single-hospital design and lack of external validation, further multicenter validation is needed before routine clinical use.

Akemat Wongpairin, Ibteesan Che-u-bong, Kulaya Chaibunma et al. · 0 citations
Open access Sep 2026

Development of an interpretable machine learning model for predicting in-hospital mortality in ICU patients with sepsis: a retrospective cohort study

An interpretable RF-based machine learning model for predicting in-hospital mortality in patients with sepsis was developed and internally validated and showed acceptable discrimination, reasonable calibration, and potential clinical net benefit in internal validation.

Tian-Yu Zhao, Ke-Xin Wen, Xu-Min Han et al. · 0 citations
Open access Sep 2026

Machine learning models for predicting liver cancer: a real-world cohort study in China

The findings support the feasibility of leveraging large-scale inpatient laboratory data for risk-stratification model development and show good discrimination and interpretability for liver cancer prediction in a hospitalized real-world cohort using routinely available clinical and laboratory data.

Ce-Xiong Fu, Fang Li, Shi-Bing Li et al. · 0 citations
Open access Aug 2026

Predictive modeling for mortality risk in elderly patients with pulmonary embolism using machine learning algorithms

ML-based models exhibit strong predictive capabilities for identifying elderly patients with PE who are at risk of hospital mortality, and can aid physicians in the early detection of high-risk patients, facilitating timely and appropriate preventive interventions.

T. Chu, Ling Ji, Ding-yu Tan et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.